Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.

作者: Sylvie Lemonde , Lisheng Du , David Bakish , Pavel Hrdina , Paul R. Albert

DOI: 10.1017/S1461145704004699

关键词:

摘要: Antidepressants, such as serotonin or noradrenaline reuptake inhibitors (e.g. fluoxetine, nefadozone) 5-HT1A agonists (flibanserin), desensitize the autoreceptor, which may contribute to their clinical efficacy. The receptor gene is repressed by NUDR/DEAF-1 in raphe cells at C-, but not G-allele of C(-1019)G polymorphism that associated with major depression and suicide. Depressed patients (n=118) were treated antidepressants including fluoxetine nefadozone combined pindolol flibanserin alone. severity was assesssed using Hamilton Rating Scale for Depression. Although had similar initially, those homozygous G(-1019) genotype responded significantly less (p=0.039) pooled antidepressant treatment groups (p=0.0497) approximately twice likely be non-responders C(-1019)C genotype. These results implicate a potential marker response, suggesting role repression gene.

参考文章(23)
B Arias, M J Arranz, C Gasto, R Catalan, L Pintor, B Gutierrez, R W Kerwin, L Fananas, Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT 1A receptor gene as putative risk factors in major depression Molecular Psychiatry. ,vol. 7, pp. 930- 932 ,(2002) , 10.1038/SJ.MP.4001146
Claudia Rothe, Lise Gutknecht, Christine Freitag, Ralf Tauber, Rainald Mössner, Petra Franke, Jürgen Fritze, Gerd Wagner, Gregor Peikert, Berit Wenda, Philipp Sand, Christian Jacob, Marcella Rietschel, Markus M. Nöthen, Henk Garritsen, Rolf Fimmers, Jürgen Deckert, Klaus-Peter Lesch, Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. The International Journal of Neuropsychopharmacology. ,vol. 7, pp. 189- 192 ,(2004) , 10.1017/S1461145703004061
D. Bakish, C. L. Hooper, M. D. Thornton, A. Wiens, C. A. Miller, C. A. Thibaudeau, Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. International Clinical Psychopharmacology. ,vol. 12, pp. 91- 97 ,(1997) , 10.1097/00004850-199703000-00004
S. Wu, D. E. Comings, A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatric Genetics. ,vol. 9, pp. 105- 106 ,(1999) , 10.1097/00041444-199906000-00010
Maurizio Fava, Kenneth S Kendler, Major Depressive Disorder Neuron. ,vol. 28, pp. 335- 341 ,(2000) , 10.1016/S0896-6273(00)00112-4
Alexander Neumeister, Earle Bain, Allison C Nugent, Richard E Carson, Omer Bonne, David A Luckenbaugh, William Eckelman, Peter Herscovitch, Dennis S Charney, Wayne C Drevets, Reduced Serotonin Type 1A Receptor Binding in Panic Disorder The Journal of Neuroscience. ,vol. 24, pp. 589- 591 ,(2004) , 10.1523/JNEUROSCI.4921-03.2004
Lynne E Rueter, Pierre Blier, Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain British Journal of Pharmacology. ,vol. 126, pp. 627- 638 ,(1999) , 10.1038/SJ.BJP.0702344
Raffaella Zanardi, Alessandro Serretti, David Rossini, Linda Franchini, Cristina Cusin, Enrico Lattuada, Danilo Dotoli, Enrico Smeraldi, Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biological Psychiatry. ,vol. 50, pp. 323- 330 ,(2001) , 10.1016/S0006-3223(01)01118-0
E Smeraldi, R Zanardi, F Benedetti, D Di Bella, J Perez, M Catalano, Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molecular Psychiatry. ,vol. 3, pp. 508- 511 ,(1998) , 10.1038/SJ.MP.4000425